SAXENDA.
Some research has explored GLP-1 receptor agonists in neurodegenerative conditions such as Parkinson's disease and Alzheimer's disease, with mixed early findings that cannot be generalised to ADHD
Retatrutide (development code LY3437943 ) is a single synthetic peptide developed by Eli Lilly that acts as a triple agonist at three receptors simultaneously: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor
Bupropion does not typically cause temperature sensitivity, but the stimulant-like properties can cause sweating in some users, creating a confusing situation where someone feels cold from tirzepatide weight loss but sweats from bupropion norepinephrine activity
In a clinical study conducted by Nordio et al., the effectiveness of myo-Ins-Se, which includes myo-inositol at a dose of 600 mg/day and selenium at a dose of 83 g/day, was examined in 86 patients with Hashimotos disease and subclinical hypothyroidism over a six-month period [41]
